TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Gene Therapy Market Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 200+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type [Yahoo! Finance]
Taysha Gene Therapies (TSHA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]
Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
Form SCHEDULE 13G Taysha Gene Therapies, Filed by: Vestal Point Capital, LP
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RTW INVESTMENTS, LP
Form 4 Taysha Gene Therapies, For: Feb 04 Filed by: Alam Kamran
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.